Objective To evaluate a tech-enabled collaborative care program in an obstetrics and gynecology (OB/GYN) practice for the treatment of perinatal depression and anxiety symptoms. Methods We conducted a retrospective cohort chart review from the electronic medical records of N = 185 patients enrolled in a pilot perinatal collaborative care program delivered by a behavioral health company, Family Well Health, in partnership with a large OB/GYN practice in Massachusetes (USA). FamilyWell’s collaborative care model (CoCM) provides telehealth sessions with a certified perinatal behavioral health coach or a licensed therapist, medication management, and implementation assistance to enhance depression screening, assessment, and treatment of perinatal mood and anxiety disorders (PMADs). English-speaking adults aged <InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(\ge \)</EquationSource> </InlineEquation> 18 years who screened positive for depression (Edinburgh Postnatal Depression Scale [EPDS] score <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(\ge \)</EquationSource> </InlineEquation> 10) by their OB/GYN clinician were referred to the FamilyWell program. Enrolled patients received weekly or biweekly telehealth sessions with a certified coach or licensed therapist and completed monthly electronic symptom assessments for anxiety (Generalized Anxiety Disorder 7-item scale [GAD-7]) and depression (Patient Health Questionnaire 9-item scale [PHQ-9]). Assessment scores were monitored by a behavioral care manager. We evaluated three clinical outcomes including change in GAD-7 and PHQ-9 scores, treatment response (50% or greater decrease in GAD-7 or PHQ-9 scores), and symptom remission (follow-up PHQ-9 or GAD-7 score < 5). Results Over 80% of referred patients enrolled in CoCM and more than 70% completed their intake session within one week. At baseline, 86% had a positive GAD-7 or PHQ-9 score (GAD-7 or PHQ-9 <InlineEquation ID="IEq3"> <EquationSource Format="TEX">\(\ge \)</EquationSource> </InlineEquation> 10 indicating symptoms of moderate, moderate-severe, or severe depression or anxiety). Patients received services from a certified coach (77%) or therapist (23%). PHQ-9 scores decreased by 1.3 points per month (95% CI [− 1.5, − 1.2], p < .001) and GAD-7 scores decreased by 1.3 points per month (95% CI [− 1.5, − 1.2], p < .001). Forty-seven percent of patients (n = 33) demonstrated depression treatment response and 52% (n = 45) demonstrated anxiety treatment response. In addition, 30% of patients (n = 26) experienced anxiety symptom remission in a mean time of 3.2 months and 31% (n = 22) experienced depression symptom remission in a mean time of 3.5 months. Patients received a mean of 8 sessions with a therapist and 9 sessions with a coach before experiencing symptom remission. Conclusion These data suggest that implementing a tech-enabled, coach-driven perinatal collaborative care program is associated with decreases in depression and anxiety symptoms. Symptom remission occurred within eight sessions with a therapist or nine sessions with a coach. Unlike other psychiatric collaborative care programs described in the literature, this program uniquely addresses the behavioral health workforce shortages by integrating certified coaches as a primary intervention and utilizing telehealth- and text-based support to enable scale. Our results suggest that this integrated behavioral health approach can be implemented outside the research setting.

Clinical Outcomes of a Tech-enabled Perinatal Collaborative Care Program to Treat Depression and Anxiety

期刊论文
出版模式：

开放获取
发表日期：

2026年4月9日

查看全文

Katherine Steele,
Martha Zimmermann,
Tiffany A. Moore Simas,
Nancy Byatt,
Roshni Koli,
Melissa Sherman,
Jessica Gaulton,
Clare McNutt

摘要

Objective

To evaluate a tech-enabled collaborative care program in an obstetrics and gynecology (OB/GYN) practice for the treatment of perinatal depression and anxiety symptoms.

Methods

We conducted a retrospective cohort chart review from the electronic medical records of N = 185 patients enrolled in a pilot perinatal collaborative care program delivered by a behavioral health company, Family Well Health, in partnership with a large OB/GYN practice in Massachusetes (USA). FamilyWell’s collaborative care model (CoCM) provides telehealth sessions with a certified perinatal behavioral health coach or a licensed therapist, medication management, and implementation assistance to enhance depression screening, assessment, and treatment of perinatal mood and anxiety disorders (PMADs). English-speaking adults aged \(\ge \) 18 years who screened positive for depression (Edinburgh Postnatal Depression Scale [EPDS] score \(\ge \) 10) by their OB/GYN clinician were referred to the FamilyWell program. Enrolled patients received weekly or biweekly telehealth sessions with a certified coach or licensed therapist and completed monthly electronic symptom assessments for anxiety (Generalized Anxiety Disorder 7-item scale [GAD-7]) and depression (Patient Health Questionnaire 9-item scale [PHQ-9]). Assessment scores were monitored by a behavioral care manager. We evaluated three clinical outcomes including change in GAD-7 and PHQ-9 scores, treatment response (50% or greater decrease in GAD-7 or PHQ-9 scores), and symptom remission (follow-up PHQ-9 or GAD-7 score < 5).

Results

Over 80% of referred patients enrolled in CoCM and more than 70% completed their intake session within one week. At baseline, 86% had a positive GAD-7 or PHQ-9 score (GAD-7 or PHQ-9 \(\ge \) 10 indicating symptoms of moderate, moderate-severe, or severe depression or anxiety). Patients received services from a certified coach (77%) or therapist (23%). PHQ-9 scores decreased by 1.3 points per month (95% CI [− 1.5, − 1.2], p < .001) and GAD-7 scores decreased by 1.3 points per month (95% CI [− 1.5, − 1.2], p < .001). Forty-seven percent of patients (n = 33) demonstrated depression treatment response and 52% (n = 45) demonstrated anxiety treatment response. In addition, 30% of patients (n = 26) experienced anxiety symptom remission in a mean time of 3.2 months and 31% (n = 22) experienced depression symptom remission in a mean time of 3.5 months. Patients received a mean of 8 sessions with a therapist and 9 sessions with a coach before experiencing symptom remission.

Conclusion

These data suggest that implementing a tech-enabled, coach-driven perinatal collaborative care program is associated with decreases in depression and anxiety symptoms. Symptom remission occurred within eight sessions with a therapist or nine sessions with a coach. Unlike other psychiatric collaborative care programs described in the literature, this program uniquely addresses the behavioral health workforce shortages by integrating certified coaches as a primary intervention and utilizing telehealth- and text-based support to enable scale. Our results suggest that this integrated behavioral health approach can be implemented outside the research setting.